BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 34091649)

  • 1. Thyroid Cancer Detected on 68Ga-PMSA PET/CT.
    Usmani S; Al-Turkait D; Al-Kandari F; Ahmed N
    J Pak Med Assoc; 2021 May; 71(5):1511-1512. PubMed ID: 34091649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-Specific Membrane Antigen Expression in Metastatic Angiosarcoma Detected on 18F-PMSA PET/CT: A New Potential Prognostic Marker.
    Marafi F; Esmail A; Usmani S
    Clin Nucl Med; 2022 Feb; 47(2):e147-e148. PubMed ID: 34172597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult Bone Metastases From Hepatocellular Carcinoma Detected on 68Ga-PMSA PET/CT.
    Usmani S; Rasheed R; Al Kandari F; Ahmed N
    Clin Nucl Med; 2021 Aug; 46(8):661-663. PubMed ID: 33512948
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
    Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
    [No Abstract]   [Full Text] [Related]  

  • 6.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-Head Comparison of
    Pitalua-Cortes Q; García-Perez FO; Vargas-Ahumada J; Gonzalez-Rueda S; Gomez-Argumosa E; Ignacio-Alvarez E; Soldevilla-Gallardo I; Torres-Agredo L
    Front Endocrinol (Lausanne); 2021; 12():794759. PubMed ID: 35002972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-Prostate-Specific Membrane Antigen PET/CT in Cholangiocarcinoma: A Potential Biomarker for Targeted Radioligand Therapy?
    Marafi F; Usmani S; Esmail A
    Clin Nucl Med; 2019 Jul; 44(7):e439-e441. PubMed ID: 30985434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective intra-individual comparison of [
    Lawal IO; Mokoala KMG; Mahapane J; Kleyhans J; Meckel M; Vorster M; Ebenhan T; Rösch F; Sathekge MM
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):134-142. PubMed ID: 32424485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.
    Schmidt-Hegemann NS; Fendler WP; Buchner A; Stief C; Rogowski P; Niyazi M; Eze C; Li M; Bartenstein P; Belka C; Ganswindt U
    Radiat Oncol; 2017 Nov; 12(1):176. PubMed ID: 29126446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
    Sanli Y; Kuyumcu S; Sanli O; Buyukkaya F; İribaş A; Alcin G; Darendeliler E; Ozluk Y; Yildiz SO; Turkmen C
    Ann Nucl Med; 2017 Nov; 31(9):709-717. PubMed ID: 28900854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT.
    Bluemel C; Krebs M; Polat B; Linke F; Eiber M; Samnick S; Lapa C; Lassmann M; Riedmiller H; Czernin J; Rubello D; Bley T; Kropf S; Wester HJ; Buck AK; Herrmann K
    Clin Nucl Med; 2016 Jul; 41(7):515-21. PubMed ID: 26975008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental finding of tall cell variant papillary thyroid carcinoma on prostate-specific membrane antigen PET CT scan.
    Xie B; Lehane C; Paulus F; Ho Shon I
    J Med Imaging Radiat Oncol; 2023 Oct; 67(7):753-755. PubMed ID: 37797182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallium-68-prostate-specific membrane antigen (
    van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L
    BJU Int; 2019 Jul; 124(1):62-68. PubMed ID: 30074667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior Vena Cava Tumor Thrombus From Thyroid Cancer Detected by 68Ga-PSMA-617 PET/CT.
    Li H; Liu Y; Zang J; Yang Z; Lin Y
    Clin Nucl Med; 2021 Mar; 46(3):264-265. PubMed ID: 33351509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of [
    Frenzel T; Tienken M; Abel M; Berliner C; Klutmann S; Beyersdorff D; Schwarz R; Krüll A; Bannas P
    Strahlenther Onkol; 2018 Jul; 194(7):646-654. PubMed ID: 29572670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic performance of 68GA-PSMA PET/CTin patients with prostate cancer].
    Veliev EI; Tomilov AA; Goncharuk DA; Bogdanov AB; Golubtsova EN
    Urologiia; 2018 Jul; (3):105-110. PubMed ID: 30035428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
    van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
    BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer?
    Taywade SK; Damle NA; Bal C
    Clin Nucl Med; 2016 May; 41(5):e263-5. PubMed ID: 26914556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed Endoradiotherapy.
    Hasenauer N; Higuchi T; Deschler-Baier B; Hartrampf PE; Pomper MG; Rowe SP; Fassnacht M; Buck AK; Werner RA
    Clin Nucl Med; 2022 Jul; 47(7):651-652. PubMed ID: 35085172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.